Fount of Information

TriLink BioTechnologies社 July TriLink Messenger





mRNA Vaccines for Rapid Response to Biological Threats

The National Biodefense Strategy and Implementation Plan, published by the U.S. government in October 2022, outlines goals for countering biological threats, enhancing pandemic preparedness, and achieving global health security. This blog focuses on that document’s goal of “rapid detection and protective response” administration for viral pathogens and mRNA vaccines.

Read More



mRNA vaccines offer protection against multidrug-resistant bacteria

Thermostable mRNA vaccines promise improved protection against COVID-19

A recent npj Vaccines publication describes the use of TriLink’s CleanCap® technology to develop a novel mRNA vaccine for Pseudomonas aeruginosa, a multidrug-resistant bacterium that poses a significant global threat.

TriLink-manufactured mRNA features in a new Nature publication, which describes the development of a novel microneedle vaccine printer for manufacturing COVID-19 vaccines with long-term thermostability.

Upcoming Events


3rd mRNA-based Therapeutic Summit USA

The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for all your mRNA needs, showcasing exclusive new data from the movers and shakers in the mRNA industry.

Featured Panel Discussion

Date: July 26, 2023
Time: 12:30 p.m. ET 
Title: Next Generation Cell Therapies with mRNA Technology
Speaker: Cory Smith, Senior Product Manager, TriLink BioTechnologies

Featured Presentation

Date: July 28, 2023
Time: 2:30 p.m. ET 
Title: Next-generation mRNA design - Increasing mRNA potency with a new cap analog
Speaker: Jordana Henderson, Associate Director, mRNA Research and Development, TriLink BioTechnologies

Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。